Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Bristol-Myers' deepens focus on fibrosis with Nitto deal
Friday, November 11, 2016BristolMyers Squibb Co said on Thursday it agreed to pay Japans Nitto Denko Corp million up front for the right to its earlystage drug for liver fibrosis due to fatty liver disease NASH or hepatitis C Fibrotic diseases are characterized by inflamma...
Perrigo to review options for Multiple Sclerosis drug Tysabri
Friday, November 11, 2016Perrigo Co Plc reported a higherthanexpected adjusted quarterly profit and said it would review strategic options for royalty rights from sales of multiple sclerosis drug Tysabri Shares of the Dublinbased company which specializes in generic and ove...
Almac Group Announce £27 million Global Expansion
Friday, November 11, 2016Almac Group the global contract pharmaceutical development and manufacturing organisation is excited to announce ambitious plans to expand its operations in Europe and North America increasing its global headcount to reach by As part of its ongoin...
Mabion signs agreement for rights to sell Mabion CD20 drug in EU and Balkans
Thursday, November 10, 2016Mabion SA Said that it signed a longterm cooperation agreement with Mylan NVs whollyowned unit Mylan Ireland for exclusive rights to sell Mabion CD oncology drug biosimilar to MabTheraRituximab in all countries of the European Union and the Balkan co...
Bristol-Myers, Infinity Pharma to evaluate Opdivo with IPI-549 in advanced solid tumors
Thursday, November 10, 2016BristolMyers Squibb and infinity pharmaceuticals announce clinical collaboration to evaluate Opdivo nivolumab in combination with IPI in advanced solid tumors BristolMyers Squibb evaluation of IPI as a monotherapy continuing with combination portio...
Pfizer wins EU's approval for Ibrance as Novartis readies rival drug
Thursday, November 10, 2016US drugmaker Pfizer said on Wednesday it had won approval from the European Union for its bestselling breast cancer drug Ibrance making it the first medicine of its kind to reach the European market The decision which had been expected following a p...
British artificial intelligence firm announces license agreement with Janssen
Wednesday, November 09, 2016British artificial intelligence firm announces exclusive license agreement with Janssen for clinical stage drug candidates facilitated by Johnson Johnson innovation Benevolentai Will have sole right to develop manufacture and commercialise novel d...
Innovus Pharma Signs Exclusive License and Distribution Agreement with Elis Pharmaceuticals
Wednesday, November 09, 2016Innovus Pharmaceuticals Inc announced it has entered into its second exclusive license and distribution agreement with Elis Pharmaceuticals Ltd Elis Pharma Under the agreement Innovus Pharma granted to Elis an exclusive license to market and sell Zes...
Sorrento Therapeutics Closes Acquisition of Scilex
Wednesday, November 09, 2016Sorrento Therapeutics Inc and Scilex Pharmaceuticals Inc announced the closing of a transaction by which Sorrento acquired a majority of SCILEX Sorrento acquired approximately of the outstanding common stock of SCILEX for a net purchase price of up...
Intec Pharma makes amendment to advanced parkinson's patient's study
Tuesday, November 08, 2016Intec Pharma announces protocol amendment to phase iii study of accordion pill carbidopalevodopa in advanced parkinsons disease patients Says amendment was submitted to and reviewed by US FDA and agency had no comments to these proposed changes To...
